Condition
Antibiotic Allergy
Total Trials
7
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
14%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (3)
P 1 (1)
P 2 (1)
P 4 (1)
Trial Status
Recruiting3
Completed2
Unknown1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT06406114Phase 2Recruiting
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
NCT06771440Not ApplicableRecruitingPrimary
Support Tool for Antibiotic Allergy deLabeling
NCT05420935Not ApplicableRecruiting
Repertoire and Properties of Anti-drug Antibodies Involved in Immediate Hypersensitivity in the Operating Room
NCT05561777Not ApplicableWithdrawnPrimary
Penicillin Allergy Risk-Stratification and Delabeling of Low-Risk Patients
NCT03158831Phase 1Completed
Drug Challenges Without Prior Skin Testing
NCT03199911Phase 4Completed
Topical Antibiotic Prophylaxis for Eyelids
NCT03164044Unknown
Improved Basophil Activation Test (BAT) in the Diagnostics of Drug Allergy
Showing all 7 trials